Physician profile
Joshua Wolf
NPI 1568637387
$24,158.32
in general payments reported to CMS, 2019-2025
12 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 76% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $117 · 2022: $13K · 2023: $5,629 · 2024: $3,907 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,705 · Food and Beverage: $2,293 · Honoraria: $1,475 · Travel and Lodging: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,705.00 |
| Food and Beverage | $2,292.85 |
| Honoraria | $1,475.00 |
| Travel and Lodging | $373.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $15,849.17 | 2022-2025 | |
| Thd America, INC. | $4,986.77 | 2021-2025 | |
| Stryker Corporation | $1,316.27 | 2022-2025 | 1788 |
| Axonics, INC. | $486.93 | 2022-2023 | Axonics |
| Ethicon US, LLC | $424.08 | 2022-2025 | Echelon Endopath, Stratafix, Echelon; Endopath |
| Medtronic, INC. | $323.83 | 2024-2025 | Signia, Ligasure |
| Boston Scientific Corporation | $245.61 | 2025 | Overstitch Endoscopic Suturing System, Spyglass Discover |
| Intuitive Surgical, INC. | $224.04 | 2019 | |
| Davol INC. | $142.15 | 2023 | Phasix Mesh |
| Janssen Biotech, INC. | $89.26 | 2025 | Tremfya |
| Activ Surgical, INC. | $41.87 | 2023-2024 | Activsight |
| Heron Therapeutics, INC. | $28.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.